The latest closing stock price for Axsome Therapeutics as of September 19, 2024 is 94.32.
An investor who bought $1,000 worth of Axsome Therapeutics stock at the IPO in 2015 would have $9,792 today, roughly 10 times their original investment - a 30.25% compound annual growth rate over 9 years.
The all-time high Axsome Therapeutics stock closing price was 106.24 on December 26, 2019.
The Axsome Therapeutics 52-week high stock price is 98.40, which is 4.3% above the current share price.
The Axsome Therapeutics 52-week low stock price is 55.02, which is 41.7% below the current share price.
The average Axsome Therapeutics stock price for the last 52 weeks is 77.52.
An investor who bought $1,000 worth of Axsome Therapeutics stock at the IPO in 2015 would have $9,792 today, roughly 10 times their original investment - a 30.25% compound annual growth rate over 9 years.
The all-time high Axsome Therapeutics stock closing price was 106.24 on December 26, 2019.
The Axsome Therapeutics 52-week high stock price is 98.40, which is 4.3% above the current share price.
The Axsome Therapeutics 52-week low stock price is 55.02, which is 41.7% below the current share price.
The average Axsome Therapeutics stock price for the last 52 weeks is 77.52.